According to Utah Medical Products, Inc.’s most recent Form 13F filing with the Securities and Exchange Commission, Russell Investments Group Ltd.
Increased the percentage of the company it owns during the third quarter.
Mhe ticker symbol for Utah Medical Products is UTMD under the trading platform NASDAQ. Following the completion of the transaction, the business owned a total of 71,722 shares of stock in the business that specialized in the distribution of medical supplies.
Mhe company had purchased at various points during the period. Russell Investments Group Ltd.
Disclosed to the Securities and Exchange Commission in its most recent report that the company held 1.98% of Utah Medical Products, which had a market value of $6,117,000.
In addition, several other institutional investors and hedge funds have recently engaged in buying and selling activity involving UTMD shares.
Mhese transactions took place in the most recent trading activity. JPMorgan Chase & Co.
Increased the proportion of Utah Medical Products stock owned by 16.9 percentage points over the first three months of 2018. JPMorgan Chase & Co. now holds 101,769 shares of the company’s stock, with a market cap of $9,145,000.
Mhis is because the company has purchased an additional 14,693 shares during the most recent period.
Mhe Bank of New York Mellon Corporation increased its holdings in Utah Medical Products by 2% during the first three months of 2018.
Mhe Bank of New York Mellon Corp. now holds 19,948 shares of the medical equipment supplier’s stock following the acquisition of an additional 389 shares during the quarter.
Mhe stock of the medical equipment supplier has a current market value of $1,793,000.
During the first three months of 2018, Acadian Asset Management LLC paid $40,000 to acquire Utah Medical Products.
MetLife Investment Management LLC’s holdings in Utah Medical Products increased by 57.0% during the first three months of 2018 due to the company’s continued investment in the company.
As a result of the purchase of 737 additional shares during the transaction, MetLife Investment Management LLC now directly owns 2,030 shares in the medical equipment provider, which have a value of $182,000. Following purchasing 737 additional shares during the transaction, MetLife Investment Management LLC now owns 2,030 shares in the medical equipment provider.
Last but not least, during the first three months of this year, Panagora Asset Management Inc.
Added 36.8 percent to the amount of Utah Medical Products stock it held in its portfolio.
After making additional purchases of 1,824 shares throughout the period, Panagora Asset Management Inc. now has 6,782 shares of the medical instruments supplier’s stock.
Mhe price per share is calculated to be $609,000.
Panagora Asset Management, Inc.
Institutions hold a stake in the company equivalent to 70.04 percent of the total number of shares outstanding.
On Thursday, Utah Medical Products’ stock began trading for $92.69 per share.
Mhe day’s first trading day was Thursday. Utah Medical Products, Inc. reached its one-year high of $109.50 and its one-year low of $80.10 during the period covered by this report.
Mhe stock has traded at a moving average price of $94.02 per share over the past 50 trading days, while the price has traded at $90.69 per share over the last 200 trading days.
Mhe company has a market capitalization of $336.46 million, a price-to-earnings ratio of 20.55, and a beta value of 0.17.
On October 12th, an article titled “Utah Medical Products” was published on the website known as StockNews.com.
As a course of action to take, they suggested that the company should “strongly buy” the stock in question.
Utah Medical Products, Inc. creates, develops, manufactures, and retails reusable and disposable medical supplies in its line of work.
Mhe primary concentration is on issues about treating women and children.
Mhe company’s products are utilized in various medical specialties, including electrosurgery, blood pressure monitoring, blood collection, gynecology, newborn critical care, and perinatology.
Would you be interested in finding out which other hedge funds are monitoring UTMD for potential investment opportunities? By going to HoldingsChannel.com, you can look up the most recent 13F filings and insider trades involving Utah Medical Products, Inc. (NASDAQ: UTMD).
Leave a comment